DEFLAZACORT

DEFDOZE / FRIZCORT 6

COMPOSITION
DEFLAZACORT6 MG 30 MG
SPECIFICATION
FORMTABLETTABLETPEDIATRIC
PACKING10X10 1X1030ml
PACKING TYPEALU ALUALU ALU
MRP850 / 900480068

ALSO AVAILABLE

DESCRIPTION

Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was approved in February, 2017 by the FDA for use in treatment of Duchenne muscular dystrophy (trade name Emflaza).

SIDE EFFECTS

The LD50 for the oral dose is greater than 4000 mg/kg in laboratory animals.

INDICATION

corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.